<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02225249</url>
  </required_header>
  <id_info>
    <org_study_id>250-14</org_study_id>
    <nct_id>NCT02225249</nct_id>
  </id_info>
  <brief_title>VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation</brief_title>
  <acronym>VASCULUX</acronym>
  <official_title>Examination of the Pulmonary Vascular Barrier in Patients During Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung transplantation is a well established method for surgical therapy for patients with end&#xD;
      stage pulmonary disease.&#xD;
&#xD;
      The investigators seek to determine to which extent the pulmonary vascular barrier gets&#xD;
      harmed during lung transplantation and whether pulmonary edema after reperfusion can be&#xD;
      monitored with measurement of extravascular lung water index (ELWI).&#xD;
&#xD;
      Additionally the investigaors are going to evaluate the correlation between ELWI and shedding&#xD;
      of the endothelial glycocalyx.&#xD;
&#xD;
      The study is designed as a prospective observational cohort study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed as a single center prospective observational cohort study including&#xD;
      only patients who are undergoing lung transplantation due to endstage pulmonary disease.&#xD;
&#xD;
      It is well known that pulmonary edema is one of the major problems following reperfusion of&#xD;
      the new organ.&#xD;
&#xD;
      The glycocalyx is located on the apical surface of vascular endothelial cells which line the&#xD;
      vascular lumen. The endothelial glycocalyx consists of mainly proteoglycans that covers,&#xD;
      among others, leukocyte and thrombocyte receptors and fulfills its principal role in&#xD;
      maintaining plasma and vessel wall homeostasis.&#xD;
&#xD;
      In patients undergoing cardiac surgery studies showed regional as well as global ischemia&#xD;
      causing an increase of syndecan-1 and heparansulphate in plasma during reperfusion.&#xD;
&#xD;
      The extent of the pulmonary vascular barrier's damage might serve as predictor for&#xD;
      postoperative complications as reperfusion edema of the lungs.&#xD;
&#xD;
      To quantify the extent of damage the investigators seek to evaluate the correlation between&#xD;
      ELWI and the damage to the vascular barrier. ELWI will be assessed using transpulmonary&#xD;
      thermodilution. Components of the vascular barrier will be quantified using ELISA-technique.&#xD;
      10 ml full blood will be drawn at 7 different predifined measurement points named T0-T7 as&#xD;
      follows:&#xD;
&#xD;
        -  T0 before induction of anesthesia&#xD;
&#xD;
        -  T1 before reperfusion of the first lung&#xD;
&#xD;
        -  T2 5 min after reperfusion of the first lung&#xD;
&#xD;
        -  T3 before reperfusion of the second lung&#xD;
&#xD;
        -  T4 5 min after reperfusion of the second lung&#xD;
&#xD;
        -  T5 before admission to the intensive care unit&#xD;
&#xD;
        -  T6 6h after reperfusion of the last lung&#xD;
&#xD;
        -  T7 12h after reperfusion of the last lung&#xD;
&#xD;
      For statistical analysis Student's t-test, Friedman or Wilcoxon rank test will be used, as&#xD;
      indicated.&#xD;
&#xD;
      Expected length of the study is 2 years enrolling 30 patients undergoing lung&#xD;
      transplantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Components of the vascular barrier</measure>
    <time_frame>Repeated mesurements to detect differences from baseline values (T0).</time_frame>
    <description>Repeated measurements of each parameter to detect the difference from baseline values.&#xD;
Each component will be measured at time point: T0, T1, T2, T3, T4 and T5.&#xD;
Components to be measured [Unit]:&#xD;
Syndecan-1 [ng/ml]&#xD;
Hyaluronan [ng/ml]&#xD;
Heparan-Sulphate [ng/ml]&#xD;
Angiopoetin-1 [ng/ml]&#xD;
Angiopoetin-2 [ng/ml]&#xD;
Components getting measured using serum or plasma samples.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Extravascular Lung Water Index (ELWI)</measure>
    <time_frame>repeated measurement of ELWI to detect differences from baseline (T0)</time_frame>
    <description>Increase of the Extravascular Lung Water Index (ELWI) will be determined using thermodilution-method.&#xD;
Repeated measurement of ELWI to detect the difference from baseline values.&#xD;
Each component will be measured at time point: T0, T5, T6 and T7.&#xD;
Unit of measurement: [ml/kg]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical parameters</measure>
    <time_frame>Repeated measurement of each parameter to detect differences from baseline (T0)</time_frame>
    <description>Follwowing clinicals parameters will be assessed at eacht time point to detect increases or decreases from baseline [Units]:&#xD;
Each parameter will be assessed at time point: T0, T1, T2, T3, T4, T5, T6, T7&#xD;
Oxygenation index [mmHg/FiO2]&#xD;
Heart rate [beats per min]&#xD;
Systolic blood pressure [mmHg]&#xD;
Mean arterial blood pressure [mmHg]&#xD;
Necessity of extracorporal lung assist [yes/no]&#xD;
The investigators assess clinical parameters as oxygenation index, heartrate, blood pressure.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>End Stage Chronic Obstructive Airways Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be taken. In summary, 61.2 ml blood will be collected at 7 specific time&#xD;
      points.&#xD;
&#xD;
      Components of the vascular barrier are examined, in detail hyaluronan, syndecan-1, and&#xD;
      angiopoietin-2.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible for this study are all patients being full of age and younger than 65 years&#xD;
        scheduled for lung transplantation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 and younger than 65 years of age&#xD;
&#xD;
          -  Scheduled for lung transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Necessity of ECMO implementation before induction of general anesthesia&#xD;
&#xD;
          -  Mechanical ventilation before lung transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Bruegger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Faculty of Ludwig-Maximilians-University Munich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dirk Bruegger, MD</last_name>
    <phone>+4989440076414</phone>
    <email>dirk.bruegger@med.uni-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Irlbeck, MD</last_name>
    <phone>+4989440073407</phone>
    <email>thomas.irlbeck@med.uni-muenchen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Dirk Bruegger, MD</last_name>
      <phone>+4989440076414</phone>
      <email>dirk.bruegger@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Dirk Bruegger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>August 4, 2014</study_first_submitted>
  <study_first_submitted_qc>August 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2014</study_first_posted>
  <last_update_submitted>August 22, 2014</last_update_submitted>
  <last_update_submitted_qc>August 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Dirk Bruegger MD</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

